Opthea Ltd(OPT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

OPT Opthea Ltd

停牌 05-05 10:55:38 EDT

3.41

+0.00

0.00%

最高3.41	最低3.41	成交量0.00
今开3.41	昨收3.41	日振幅0.00%
总市值5.25亿	流通市值3.35亿	总股本1.54亿
成交额0.00	换手率0.00%	流通股本9,825万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"OPT","market":"US","secType":"STK","nameCN":"Opthea Ltd","latestPrice":3.41,"timestamp":1746456938415,"preClose":3.41,"halted":3,"volume":0,"delay":0,"floatShares":98250824,"shares":153910805,"eps":-2.105144,"marketStatus":"停牌","change":0,"latestTime":"05-05 10:55:38 EDT","open":3.41,"high":3.41,"low":3.41,"amount":0,"amplitude":0,"askPrice":3.5,"askSize":1600,"bidPrice":3.36,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.105144,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1746475200000},"marketStatusCode":2,"adr":0,"adrRate":8,"listingDate":1602820800000,"exchange":"NASDAQ","adjPreClose":3.41,"volumeRatio":0},"requestUrl":"/m/hq/s/OPT","defaultTab":"news","newsList":[{"id":"2518275591","title":"Opthea Limited盘中异动 股价大跌5.47%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518275591","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518275591?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:31","pubTimestamp":1741613487,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时31分，Opthea Limited股票出现波动，股价大幅跳水5.47%。Opthea Limited股票所在的生物技术行业中，整体跌幅为0.59%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为1808.81%、383.42%、45.40%，振幅较大的相关个股有Xencor, Inc.、Y-Mabs Therapeutics, Inc.、Aditxt, Inc.，振幅分别为99.13%、94.67%、10.29%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213127abf2fbce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213127abf2fbce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPT","CKDXF","BK4139"],"gpt_icon":0},{"id":"2517166023","title":"Opthea Limited盘中异动 早盘股价大跌7.54%报3.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517166023","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517166023?lang=zh_cn&edition=full","pubTime":"2025-03-06 22:36","pubTimestamp":1741271815,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日22时36分，Opthea Limited股票出现波动，股价快速跳水7.54%。截至发稿，该股报3.68美元/股，成交量1256股，换手率0.00%，振幅6.38%。Opthea Limited股票所在的生物技术行业中，整体跌幅为0.52%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223655989eb589&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306223655989eb589&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OPT","CKDXF"],"gpt_icon":0},{"id":"2517946983","title":"Opthea Limited盘中异动 急速拉升12.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517946983","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517946983?lang=zh_cn&edition=full","pubTime":"2025-03-05 22:31","pubTimestamp":1741185080,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日22时31分，Opthea Limited股票出现异动，股价急速上涨12.96%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.08%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223120a260c719&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305223120a260c719&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CKDXF","OPT","BK4139"],"gpt_icon":0},{"id":"2516779066","title":"Opthea Limited盘中异动 急速下跌6.85%报4.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516779066","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516779066?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:34","pubTimestamp":1741098861,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日22时34分，Opthea Limited股票出现波动，股价快速下跌6.85%。截至发稿，该股报4.76美元/股，成交量5103股，换手率0.00%，振幅8.02%。Opthea Limited股票所在的生物技术行业中，整体跌幅为0.08%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223421a25f058f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304223421a25f058f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPT","BK4139","CKDXF"],"gpt_icon":0},{"id":"2516637590","title":"Opthea Limited盘中异动 早盘大幅上涨6.70%报4.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516637590","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516637590?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:01","pubTimestamp":1741014084,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时01分，Opthea Limited股票出现波动，股价急速拉升6.70%。截至发稿，该股报4.78美元/股，成交量998股，换手率0.00%，振幅7.14%。Opthea Limited股票所在的生物技术行业中，整体跌幅为0.05%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032301249637b4d2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503032301249637b4d2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPT","BK4139","CKDXF"],"gpt_icon":0},{"id":"2516301505","title":"Opthea Limited盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516301505","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516301505?lang=zh_cn&edition=full","pubTime":"2025-03-01 04:54","pubTimestamp":1740776069,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日04时54分，Opthea Limited股票出现波动，股价急速下挫5.00%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.77%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010454309634672b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503010454309634672b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPT","BK4139","CKDXF"],"gpt_icon":0},{"id":"2514890523","title":"Opthea Limited盘中异动 早盘股价大涨7.14%报4.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514890523","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514890523?lang=zh_cn&edition=full","pubTime":"2025-02-27 23:07","pubTimestamp":1740668843,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日23时07分，Opthea Limited股票出现异动，股价急速拉升7.14%。截至发稿，该股报4.95美元/股，成交量2673股，换手率0.00%，振幅9.96%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.83%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272307239632b91e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272307239632b91e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPT","BK4139","CKDXF"],"gpt_icon":0},{"id":"2513296624","title":"Opthea Limited盘中异动 股价大涨5.48%报5.26美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513296624","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513296624?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:44","pubTimestamp":1740149093,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时44分，Opthea Limited股票出现异动，股价大幅拉升5.48%。截至发稿，该股报5.26美元/股，成交量1121股，换手率0.00%，振幅0.00%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.42%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221224453988de171&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221224453988de171&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CKDXF","OPT","BK4139"],"gpt_icon":0},{"id":"2512483317","title":"Opthea Limited盘中异动 早盘大幅拉升5.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512483317","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512483317?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:31","pubTimestamp":1739975474,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时31分，Opthea Limited股票出现异动，股价快速拉升5.65%。Opthea Limited股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Osr Holdings, Inc.、Aditxt, Inc.、Cellectar Biosciences, Inc.涨幅较大，Aditxt, Inc.、Alzamend Neuro, Inc.、Chemomab Therapeutics Ltd较为活跃，换手率分别为202.21%、201.40%、65.46%，振幅较大的相关个股有Allogene Therapeutics, Inc.、Azitra Inc、Cellectar Biosciences, Inc.，振幅分别为16.90%、11.29%、6.05%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223114abd4fdf1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223114abd4fdf1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OPT","CKDXF"],"gpt_icon":0},{"id":"2512016782","title":"Opthea Limited盘中异动 股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512016782","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512016782?lang=zh_cn&edition=full","pubTime":"2025-02-19 00:25","pubTimestamp":1739895926,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日00时25分，Opthea Limited股票出现波动，股价大幅跳水5.17%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.64%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190025279627ab5e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190025279627ab5e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPT","BK4139","CKDXF"],"gpt_icon":0},{"id":"2511696764","title":"Opthea Limited盘中异动 股价大涨5.81%报5.46美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511696764","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511696764?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:32","pubTimestamp":1739543533,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时32分，Opthea Limited股票出现异动，股价大幅上涨5.81%。截至发稿，该股报5.46美元/股，成交量2859股，换手率0.00%，振幅0.00%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.24%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422321396231b7f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422321396231b7f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPT","BK4139","CKDXF"],"gpt_icon":0},{"id":"2510333036","title":"Opthea Limited盘中异动 股价大跌5.40%报5.24美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510333036","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510333036?lang=zh_cn&edition=full","pubTime":"2025-02-11 23:26","pubTimestamp":1739287597,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日23时26分，Opthea Limited股票出现异动，股价大幅下挫5.40%。截至发稿，该股报5.24美元/股，成交量3.0715万股，换手率0.02%，振幅5.33%。Opthea Limited股票所在的生物技术行业中，整体跌幅为1.61%。其相关个股中，Ocean Biomedical, Inc.、Ocean Biomedical Inc C/Wts 14/02/2028 、Lipella Pharmaceuticals Inc.涨幅较大，Lipella Pharmaceuticals Inc.、Ocean Biomedical, Inc.、Dominari Holdings Inc.较为活跃，换手率分别为2617.43%、948.34%、356.16%，振幅较大的相关个股有Dominari Holdings Inc.、Ocean Biomedical, Inc.、In8Bio, Inc.，振幅分别为58.60%、57.43%、37.99%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211232638a2420771&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211232638a2420771&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OPT","CKDXF"],"gpt_icon":0},{"id":"2510863061","title":"Opthea Limited盘中异动 股价大跌6.11%报5.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510863061","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510863061?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:31","pubTimestamp":1739197900,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时31分，Opthea Limited股票出现异动，股价快速跳水6.11%。截至发稿，该股报5.38美元/股，成交量4868股，换手率0.00%，振幅0.00%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.38%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223140a240a1da&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223140a240a1da&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CKDXF","BK4139","OPT"],"gpt_icon":0},{"id":"2509277707","title":"Opthea Limited盘中异动 大幅拉升5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509277707","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509277707?lang=zh_cn&edition=full","pubTime":"2025-02-06 23:01","pubTimestamp":1738854098,"startTime":"0","endTime":"0","summary":"北京时间2025年02月06日23时01分，Opthea Limited股票出现异动，股价快速上涨5.08%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.01%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206230138987c941c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250206230138987c941c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","CKDXF","OPT"],"gpt_icon":0},{"id":"2509282607","title":"Opthea Limited盘中异动 早盘大幅拉升5.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509282607","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509282607?lang=zh_cn&edition=full","pubTime":"2025-02-05 22:35","pubTimestamp":1738766155,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日22时35分，Opthea Limited股票出现波动，股价大幅上涨5.75%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.86%。其相关个股中，Oragenics Inc.、Pasithea Therapeutics Corp.、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Pasithea Therapeutics Corp.、Oragenics Inc.、60 Degrees Pharmaceuticals, Inc.较为活跃，换手率分别为2939.46%、752.04%、624.31%，振幅较大的相关个股有Oragenics Inc.、60 Degrees Pharmaceuticals, Inc.、Pasithea Therapeutics Corp C/Wts 12/08/2026 ，振幅分别为34.67%、23.35%、22.22%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223555987b7c91&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205223555987b7c91&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPT","BK4139","CKDXF"],"gpt_icon":0},{"id":"2508142590","title":"Opthea Limited盘中异动 股价大跌9.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508142590","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508142590?lang=zh_cn&edition=full","pubTime":"2025-02-03 23:10","pubTimestamp":1738595413,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日23时10分，Opthea Limited股票出现异动，股价快速跳水9.53%。Opthea Limited股票所在的生物技术行业中，整体跌幅为0.68%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203231014a2381208&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203231014a2381208&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CKDXF","OPT","BK4139"],"gpt_icon":0},{"id":"2508814962","title":"Opthea Limited盘中异动 股价大涨6.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508814962","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508814962?lang=zh_cn&edition=full","pubTime":"2025-01-31 23:33","pubTimestamp":1738337605,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日23时33分，Opthea Limited股票出现波动，股价快速拉升6.31%。Opthea Limited股票所在的生物技术行业中，整体涨幅为1.38%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501312333259877671e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501312333259877671e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPT","BK4139","CKDXF"],"gpt_icon":0},{"id":"2507723036","title":"Opthea Limited盘中异动 下午盘股价大涨6.07%报5.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507723036","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507723036?lang=zh_cn&edition=full","pubTime":"2025-01-31 03:07","pubTimestamp":1738264071,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日03时07分，Opthea Limited股票出现波动，股价快速上涨6.07%。截至发稿，该股报5.38美元/股，成交量1.4397万股，换手率0.01%，振幅5.82%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.37%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013103075196145b88&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025013103075196145b88&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPT","BK4139","CKDXF"],"gpt_icon":0},{"id":"2507680826","title":"HC Wainwright & Co.：重申Opthea(OPT.US)评级，由买入调整至买入评级, 目标价由12.00美元调整至12.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2507680826","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507680826?lang=zh_cn&edition=full","pubTime":"2025-01-29 20:21","pubTimestamp":1738153265,"startTime":"0","endTime":"0","summary":"HC Wainwright & Co.：重申Opthea(OPT.US)评级，由买入调整至买入评级, 目标价由12.00美元调整至12.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/29202147897464.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["OPT"],"gpt_icon":0},{"id":"2506514665","title":"Opthea Limited盘中异动 快速拉升5.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506514665","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506514665?lang=zh_cn&edition=full","pubTime":"2025-01-28 22:34","pubTimestamp":1738074882,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日22时34分，Opthea Limited股票出现波动，股价快速拉升5.66%。Opthea Limited股票所在的生物技术行业中，整体涨幅为0.07%。Opthea Limited公司简介：Opthea Ltd 经营的一个行业是医疗技术和医疗保健。Opthea 的开发活动基于涵盖关键靶点血管内皮生长因子 VEGF-C、VEGF-D 和 VEGF 受体-3 的知识产权组合，用于治疗与血液和淋巴管生长以及血管渗漏相关的疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501282234429612f4af&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501282234429612f4af&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OPT","CKDXF","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.opthea.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":-0.3867},{"period":"6month","weight":-0.2143},{"period":"1year","weight":0.0271},{"period":"ytd","weight":-0.1318}],"compareEarnings":[{"period":"1week","weight":0.0293},{"period":"1month","weight":0.004},{"period":"3month","weight":-0.0583},{"period":"6month","weight":-0.0075},{"period":"1year","weight":0.1222},{"period":"ytd","weight":-0.033}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Opthea Limited于1984年根据澳大利亚法律注册成立，名称为Circadian Technologies Limited。该公司是一家临床阶段生物制药公司，致力于开发一种新型疗法，用于治疗高度流行和进行性视网膜疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.059641},{"month":2,"riseRate":0.2,"avgChangeRate":-0.075106},{"month":3,"riseRate":0.6,"avgChangeRate":-0.014641},{"month":4,"riseRate":0.25,"avgChangeRate":-0.067705},{"month":5,"riseRate":0.2,"avgChangeRate":-0.014435},{"month":6,"riseRate":0,"avgChangeRate":-0.185643},{"month":7,"riseRate":0.75,"avgChangeRate":0.050972},{"month":8,"riseRate":0.5,"avgChangeRate":0.036823},{"month":9,"riseRate":0.75,"avgChangeRate":0.035487},{"month":10,"riseRate":0.25,"avgChangeRate":-0.057655},{"month":11,"riseRate":0.6,"avgChangeRate":0.060069},{"month":12,"riseRate":0.8,"avgChangeRate":0.057202}],"exchange":"NASDAQ","name":"Opthea Ltd","nameEN":"Opthea Ltd"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Opthea Ltd(OPT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Opthea Ltd(OPT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Opthea Ltd,OPT,Opthea Ltd股票,Opthea Ltd股票老虎,Opthea Ltd股票老虎国际,Opthea Ltd行情,Opthea Ltd股票行情,Opthea Ltd股价,Opthea Ltd股市,Opthea Ltd股票价格,Opthea Ltd股票交易,Opthea Ltd股票购买,Opthea Ltd股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Opthea Ltd(OPT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Opthea Ltd(OPT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}